India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.

The innovator drug named Jardiance by BI costs around Rs 60 per tablet. Delhi-based Mankind Pharma launched a range of empagliflozin products, including its combinations, priced between Rs 5.5 and ...

Mankind Pharma has successfully amalgamated its three subsidiaries, namely, Shree Jee Laboratory Pvt. Ltd., JPR Labs Pvt. Ltd. and Jaspack Industries Pvt. Ltd into the company. The merger took ...

Earlier in February, the New Delhi bench of the National Company Law Tribunal (NCLT) approved the amalgamation of Shree Jee Laboratory, JPR Labs and Jaspack Industries with Mankind Pharma. In the ...

Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name Mankind Pharma Private Limited, by the Registrar of Companies, Delhi and Haryana, at New Delhi.

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed retail prices of 80 formulations under ...

Top generics makers such as Cipla, Dr Reddy’s, Lupin, Natco Pharma, Mankind Pharma, and Biocon are all gearing up to launch cheaper generic copies of Ozempic. Meanwhile, India’s largest pharma ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...

If implemented, the looming Trump administration tariffs could hit the sectors hard. There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and ...